Search clinical trials for: Maintain MAP ≥ 90 mmHg

Total 31 results

Centre Hospitalier le Mans

Not yet recruiting

Mean Arterial Pressure After Out-of-hospital Cardiac Arrest (METAPHORE)

Cardiac Arrest

France
Rigshospitalet, Denmark

Withdrawn

The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery

Anesthesia | Peripheral Arterial Diseases

Denmark
Sahlgrenska University Hospital, Sweden

Completed

The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock

Septic Shock | Acute Kidney Injury

Sweden
The University of Texas Health Science Center,...
Trauma Research and Combat Casualty Care Collaborative (TRC4)

Not yet recruiting

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

Spinal Cord Injuries

United States
Rigshospitalet, Denmark

Completed

The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia (CA)

Gastrointestinal Neoplasms | Anesthesia, General

Denmark
Rigshospitalet, Denmark
Danish Heart Foundation

Completed

Perfusion - Pressure - Creatinine Trial (PPC)

Acute Kidney Injury

Denmark
University of Colorado, Denver
United States Department of Defense

Active, not recruiting

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2)

Pathologic Processes | Disease Attributes | Critical Illness | Wounds and Injury

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders in Patients With Ischemic Stroke in the Carotid Arteries

Cognitive Disorders

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke

Ischemic Stroke | Mild Cognitive Impairment

Russian Federation
University of Colorado, Denver
United States Department of Defense

Active, not recruiting

Strategy to Avoid Excessive Oxygen in Major Burn Patients (SAVE-O2)

Pathologic Processes | Disease Attributes | Critical Illness | Wounds and Injury

United States
Centre Hospitalier le Mans

Recruiting

Early Transcranial Doppler Goal Directed Therapy After Cardiac Arrest: a Pilot Study (GOODYEAR)

Cardiac Arrest | Ischemic Reperfusion Injury | Cerebral Lesion | Ischemic Encephalopathy

France
Materia Medica Holding

Completed

Prospecta in the Treatment of Cognitive, Behavioural and Psychiatric Disorders in Patients With Vascular Dementia.

Vascular Dementia

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Prospecta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Attention Deficit Hyperactivity Disorder

Russian Federation
Université de Sherbrooke

Active, not recruiting

Optimal VAsopressor TitraTION in Patients 65 Years and Older (OVATION-65)

Hypotension | Usual Care | Vasopressors | Mean Arterial Pressure Targets

Canada
University of Southern Denmark

Recruiting

REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) (RELIEPH)

Intensive Care Unit | Out-Of-Hospital Cardiac Arrest | Mechanical Ventilation | Resuscitation | Oxygen Therapy | Hypertension, Pulmonary Arterial

Denmark
Jesper Kjaergaard
Odense University Hospital

Completed

Blood Pressure and OXygenation Targets After OHCA (BOX)

Blood Pressure | Out-of-Hospital Cardiac Arrest | Hemodynamic Instability

Denmark
Centre de recherche du Centre hospitalier universitaire...

Completed

Physiologic Study of Cerebral Perfusion

Shock | Cerebral Perfusion Pressure | Vasopressor Agents | Magnetic Resonance Imaging (MRI), Functional

Canada
Auckland City Hospital

Recruiting

MAnagement of Systolic Blood Pressure During Thrombectomy by Endovascular Route for Acute Ischaemic STROKE (MASTERSTROKE)

Stroke | Blood Pressure | Embolus Cerebral

New Zealand
HALEON

Completed

Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products

Sunscreening Agents

United States
HALEON

Completed

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products

Sunscreening Agents

United States
Assiut University

Not yet recruiting

Assessment of Cognitive Functions, Psychological Symptoms, and Quality of Life Among B Thalassemia Patients and Their Clinical Correlates.

B Thalassemia
Stanford University

Completed

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

Primary Malignant Liver Neoplasm

United States
University Hospital, Strasbourg, France

Completed

Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology

Smoking Cessation and Lung Cancer

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Stage IV Liver Cancer | Stage IVA Liver Cancer | Stage IVB Liver Cancer | Metastatic Liver Carcinoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Lymphoma | Leukemia | Graft Versus Host Disease

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Recurrent Adult Lymphoblastic... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell Myeloma | Refractory Plasma Cell Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Refractory Anemia With Excess Blasts

United States

Search clinical trials for: Maintain MAP ≥ 90 mmHg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations